Methotrexate vs expectant management for treatment of tubal ectopic pregnancy: An individual participant data meta‐analysis
Abstract Introduction Ectopic pregnancy is an important health condition which affects up to 1 in 100 women. Women who present with mild symptoms and low serum human chorionic gonadotrophin (hCG) are often treated with methotrexate (MTX), but expectant management with close monitoring is a feasible...
Saved in:
| Main Authors: | Sarah Annie Solangon, Madelon Van Wely, Norah Van Mello, Ben W. Mol, Jackie A. Ross, Davor Jurkovic |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-09-01
|
| Series: | Acta Obstetricia et Gynecologica Scandinavica |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/aogs.14617 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictors of Methotrexate Success and Fertility Outcomes in Tubal Ectopic Pregnancy: A Retrospective Cohort Study
by: Elisa Scarpelli, et al.
Published: (2025-06-01) -
Risk factors for methotrexate treatment failure in tubal ectopic pregnancy: a retrospective cohort study
by: Linru Fu, et al.
Published: (2024-12-01) -
Tubal Ectopic Pregnancy: From Diagnosis to Treatment
by: Dimitrios Papageorgiou, et al.
Published: (2025-06-01) -
Enhancing decision-making in tubal ectopic pregnancy using a machine learning approach to expectant management: a clinical article
by: Liron Jurman, et al.
Published: (2024-12-01) -
Ectopic Pregnancy: An Overview
by: Daniele Di Gennaro, et al.
Published: (2022-11-01)